Replies to post #118126 on Limitless Venture Group Inc. (LVGI)

[captainsjg]

Well on the bright side he did so what he said he was going to do. Also it looks like only 25g in toxic loans out there? I have to be wrong on that?

[$Pistol Pete$]

$LVGI....where is that on the filing? I don't see it

http://www.otcmarkets.com/financialReportViewer?symbol=LVGI&id=166706

OTC Pink® Basic Disclosure Guidelines
Federal securities laws, such as Rules 10b-5 and 15c2-11 of the Securities Exchange Act of 1934 (“Exchange Act”) as well as Rule 144
of the Securities Act of 1933 (“Securities Act”), and state Blue Sky laws, require issuers to provide adequate current information to the
public markets. With a view to encouraging compliance with these laws, OTC Markets Group has created these OTC Pink Basic
Disclosure Guidelines. We use the basic disclosure information provided by OTC Pink companies under these guidelines to designate
the appropriate tier in the OTC Pink marketplace: Current, Limited or No Information. OTC Markets Group may require companies with
securities designated as Caveat Emptor to make additional disclosures in order to qualify for OTC Pink Current Information tier.
Qualifications for the OTC Pink - Current Information Tier
Companies that make the information described below publicly available on a timely basis (90 days after fiscal year end for Annual
Reports; 45 days after each fiscal quarter end for Quarterly Reports) qualify for the Current Information Tier. Financial reports must be
prepared according to U.S. GAAP or IFRS, but are not required to be audited to qualify for the OTC Pink Current Information tier.
Initial Qualification:
1. 1. Subscribe to the OTC Disclosure & News Service on www.OTCIQ.com to publish your financial reports and material
news.
1. 2. Create the following documents, save them in PDF format and upload them via www.OTCIQ.com:
? • Annual Financial statements (Document must Include: Balance Sheet, Income Statement, Statement of
Cash Flows, Notes to Financial Statements) for the previous two fiscal years. If these reports are audited, please
attach the audit letter from the PCAOB registered audit firm. Each year’s Annual Financial statements should be
posted separately under the report type “Annual Report” in OTCIQ.
? • Any subsequent Quarterly Reports since the most recent Annual Report.
? • The most recent fiscal period end report should also include information in accordance with these OTC
Pink Basic Disclosure Guidelines; use the fillable form beginning on page 3.
• 3. If financial reports are not audited by a PCAOB registered audit firm:
? • Submit a signed Attorney Letter Agreement (first two pages of the Attorney Letter Guidelines).
? • After following the appropriate procedures with a qualified attorney, upload an Attorney Letter complying with
Attorney Letter Guidelines through your otciq.com account.
Ongoing Qualification:
• 1. For each Fiscal Quarter End, upload a Quarterly Report via www.OTCIQ.com within 45 days of the quarter end. (A
separate quarterly report is not required for the 4th quarter.) The Quarterly Report should include:
•
• Information in accordance with these OTC Pink Basic Disclosure Guidelines -- use the fillable form beginning on
page 3. Quarterly financial statements (Balance Sheet, Income Statement, Statement of Cash Flows, Notes to Financial
Statements). No Audit Letter or Attorney Letter is required.
• 2. For each Fiscal Year End, upload an Annual Report within 90 days of the fiscal year end. The Annual Report should
include:
• Information in accordance with these OTC Pink Basic Disclosure Guidelines -- use the fillable form beginning on page
3.
• Annual financial statements (Balance Sheet, Income Statement, Statement of Cash Flows, Notes to Financial
Statements, and Audit Letter, if the financial statements are audited).
• 3. If financial reports are not audited by a PCAOB registered audit firm, upload an Attorney Letter via
www.OTCIQ.com complying with the Attorney Letter Guidelines within 120 days of the fiscal year end.
OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v1.1 April 25, 2013) Page 1 of 9
Qualifications for the OTC Pink - Limited Information Tier
Companies that make the information described below publicly available within the prior 6 months qualify for the Limited Information
Tier.
• 1. Subscribe to the OTC Disclosure & News Service on www.OTCIQ.com to publish your financial reports and material
news.
• 2. Create a Quarterly Report or Annual Report for a fiscal period ended within the previous 6 months, save it in PDF
format and upload it via www.OTCIQ.com. The Quarterly Report or Annual Report includes:
Balance Sheet, Income Statement, and Total Number of Issued and Outstanding Shares. Financial statements must
be prepared in accordance with US GAAP, but are not required to be audited. (Please note that Cash Flow
Statements are not required to qualify for the Limited Information tier; however, unless the financial statements
include a Cash Flow Statement, no financial data will be included in the OTC Financials Data Service, which
distributes company financial data to online investor portals and makes the data available on your company’s
Financials tab on www.otcmarkets.com)
A company in the Limited Information tier, may, but is not required to, include information in accordance with these
OTC Pink Basic Disclosure Guidelines using the fillable form beginning on page 3.
Current Reporting of Material Corporate Events
OTC Markets Group encourages companies to make public disclosure available regarding corporate events that may be material to the
issuer and its securities. Persons with knowledge of such events would be considered to be in possession of material nonpublic
information and may not buy or sell the issuer’s securities until or unless such information is made public. If not included in the issuer’s
previous public disclosure documents or if any of the following events occur after the publication of such disclosure documents, the
issuer shall publicly disclose such events by disseminating a news release within 4 business days following their occurrence, and
posting such news release through the OTC Disclosure & News Service.
Material corporate events include:
?? • Entry or Termination of a Material Definitive Agreement
?? • Completion of Acquisition or Disposition of Assets, Including but not Limited to mergers
?? • Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of an
Issuer
?? • Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement
?? • Costs Associated with Exit or Disposal Activities
?? • Material Impairments
?? • Sales of Equity Securities
?? • Material Modification to Rights of Security Holders
?? • Changes in Issuer's Certifying Accountant
?? • Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim
Review
?? • Changes in Control of Issuer
?? • Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
?? • Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
?? • Amendments to the Issuer's Code of Ethics, or Waiver of a Provision of the Code of Ethics
?? • Other events the issuer considers to be of importance
OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v1.1 April 25, 2013) Page 2 of 9
OTC Pink Basic Disclosure Guidelines
0. 1) Name of the issuer and its predecessors (if any)
In answering this item, please also provide any names used by predecessor entities in the past five years and the dates of
the name changes.
Limitless Venture Group Inc. since January 2013 (formerly known as EnerBrite Technologies Group, Inc.)
0. 2) Address of the issuer’s principal executive offices
Company Headquarters
Address 1: Limitless Venture Group Inc.
Address 2: 121 E. 35 Street
Address 3: Tulsa, OK 74105
Phone: [phone]
Email: [e-mail]
Website(s): www.lvginc.com
IR Contact
Address 1: None
Address 2:
Address 3:
Phone:
Email:
Website(s):
0. 3) Security Information
Trading Symbol: LVGI
Exact title and class of securities outstanding: Common and Preferred Class
G
CUSIP: 532737104
Par or Stated Value: Common: $0.001; Preferred Class G: No Par
Total shares authorized: Common: 4,200,000,000; Preferred Class G: 1 as of: December 31, 2016
Total shares outstanding: Common: 3,700,000,000; Preferred Class G: 1 as of: December 31, 2016
Additional class of securities (if necessary):
Trading Symbol:
Exact title and class of securities outstanding: Class G Preferred
CUSIP:
Par or Stated Value: No Par
Total shares authorized: 1 as of: December 31, 2016
Total shares outstanding: 1 as of: December 31, 2016
Transfer Agent
Name: Olde Monmouth Stock Transfer Co., Inc.
Address 1: 200 Memorial Highway
Address 2: Atlantic Highlands, NJ 07716
Address 3:
Phone: [phone]
Is the Transfer Agent registered under the Exchange Act?* Yes: No:
*To be included in the OTC Pink Current Information tier, the transfer agent must be registered under the Exchange Act.
OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v1.1 April 25, 2013) Page 3 of 9
List any restrictions on the transfer of security:
None
Describe any trading suspension orders issued by the SEC in the past 12 months.
None
List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently
anticipated or that occurred within the past 12 months:
Effective in July 22, 2015, the Company increased its authorized Common Stock to 4,200,000,000 shares from
3,500,000,000 shares that were authorized effective October 23, 2013.
0. 4) Issuance History
List below any events, in chronological order, that resulted in changes in total shares outstanding by the issuer in the past
two fiscal years and any interim period. The list shall include all offerings of equity securities, including debt convertible
into equity securities, whether private or public, and all shares or any other securities or options to acquire such securities
issued for services, describing (1) the securities, (2) the persons or entities to whom such securities were issued and (3)
the services provided by such persons or entities. The list shall indicate:
0. A. The nature of each offering (e.g., Securities Act Rule 504, intrastate, etc.);
0. B. Any jurisdictions where the offering was registered or qualified;
0. C. The number of shares offered;
0. D. The number of shares sold;
0. E. The price at which the shares were offered, and the amount actually paid to the issuer;
0. F. The trading status of the shares; and
Whether the certificates or other documents that evidence the shares contain a legend (1) stating that the shares
have not been registered under the Securities Act and (2) setting forth or referring to the restrictions on
transferability and sale of the shares under the Securities Act.
See Supplemental Schedule filed on February 22, 2017.
OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v1.1 April 25, 2013) Page 4 of 9
Provide the financial statements described below for the most recent fiscal year end or quarter end to
maintain qualification for the OTC Pink Current Information tier. For the initial disclosure statement
(qualifying for Current Information for the first time) please provide reports for the two previous fiscal
years and any interim periods.
0. A. Balance sheet;
0. B. Statement of income;
0. C. Statement of cash flows;
0. D. Financial notes; and
1. E. Audit letter, if audited
The financial statements requested pursuant to this item shall be prepared in accordance with US GAAP by
persons with sufficient financial skills.
You may either (i) attach/append the financial statements to this disclosure statement or (ii) post such financial
statements through the OTC Disclosure & News Service as a separate report using the appropriate report name
for the applicable period end. (“Annual Report,” “Quarterly Report” or “Interim Report”).
If you choose to publish the financial reports separately as described in part (ii) above, you must state in the
accompanying disclosure statement that such financial statements are incorporated by reference. You may
reference the document(s) containing the required financial statements by indicating the document name, period
end date, and the date that it was posted to otciq.com in the field below.
Limitless Venture Group, Inc. unaudited condensed consolidated balance sheets as of December 31,
2016 and June 30, 2016, statements of operations and cash flows for the six months ended December
31, 2016 and 2015 as filed on February 22, 2017 are incorporated herein by reference.
Information contained in a Financial Report is considered current until the due date for the subsequent Financial Report.
To remain in the OTC Pink Current Information tier, a company must post its Annual Report within 90 days from its fiscal
year-end date and Quarterly Reports within 45 days of its fiscal quarter-end date.
0. 6) Describe the Issuer’s Business, Products and Services
Describe the issuer’s business so a potential investor can clearly understand the company. In answering this item, please
include the following:
A. a description of the issuer’s business operations;
Limitless Venture Group, Inc., known as THE BRAND BUILDERS, is a development stage company dedicated to the
production, distribution and marketing of unique, quality product lines. Limitless Venture Group, Inc. is a full service
brand development company with an in house Bio-Chemical engineering and formulations department, in-house
brand identity team, full graphics department as well as an experienced and highly motivated group of marketing
professionals. Limitless Venture Group Inc. and its group of diversified wholly owned subsidiaries have four product
lines ready to go to market. Through our Limitless Body Inc. subsidiary we have our Limitless Body and our Limitless
Health product lines fully developed, tested and ready for full production. Limitless Venture Group, Inc. also controls
as a 100% wholly owned subsidiary named Limitless Brands Inc. Limitless Brands Inc. serves as our alcoholic brand
division. SLAM Infusination is our line of RTD (ready to drink) alcoholic shots aimed at the virtually untapped grab and
go counter item space of the massive alcohol industry. SLAM has it owns formulation, graphics and marketing
departments. SLAM has full federal and state approvals and is ready to go market. Through Limitless Health™ and
our URL www.hempcorehealth.com, we market our HempCore Health™ line of products. The initial product lineup
consists of five products: Healthy Heart - a cholesterol reduction formula; Relax - an anti-anxiety/stress relief formula;
Brain Boost - a cognitive/brain function enhancement formula; Fibered UP - a fiber supplement and Joint Relief - a
joint/arthritis relief formula.
OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v1.1 April 25, 2013) Page 5 of 9
Limitless Venture Group, Inc. was initially funded by selling notes payable to investors for cash and receiving cash
advances from related parties. To reduce the amount of debt while retaining our cash for use to fund development of
our business, we have repaid the principal that we owe to the investors that hold our notes payable by issuing them
shares of our common stock. The overall effect has been to reduce the amount of our outstanding debt without using
our working capital. We are currently seeking additional working capital to fund our development and operations.
0. B. Date and State (or Jurisdiction) of
Incorporation: March 5, 2007 in the State of Nevada
0. C. the issuer’s primary and secondary
SIC Codes; 424210 and 325411
0.
1. D. the issuer’s fiscal year end date;
June 30
E. principal products or services, and their markets;
The Company’s line of products consist of (1) the Limitless Body line of washes, scrubs and moisturizers with its Body
Fresh, Muscle Butter, Body Sugar, Bare Skin and Gym Sani-Tproducts and (2) the Limitless Health line of natural
supplements with its LipiRestorin OTC, Prostaderol OTC and MaxTlevelin OTC products. The Limitless Health
products are positioned in the anti-aging market and, along with the Limitless Body, in the wellness/fitness market.
The Company’s SLAM product is a ready-to-drink pre-mixed 1.69 ounce alcohol shots. SLAM products are part of
the wholesale market for liquor products that consumer purchase through liquor retail stores. Through Limitless
Health™ and our URL www.hempcorehealth.com, we market our HempCore Health™ line of products. The initial
product lineup consists of five products: Healthy Heart - a cholesterol reduction formula; Relax - an anti-anxiety/stress
relief formula; Brain Boost - a cognitive/brain function enhancement formula; Fibered UP - a fiber supplement and
Joint Relief - a joint/arthritis relief formula.
7) Describe the Issuer’s Facilities
The goal of this section is to provide a potential investor with a clear understanding of all assets, properties or facilities
owned, used or leased by the issuer.
In responding to this item, please clearly describe the assets, properties or facilities of the issuer, give the location of the
principal plants and other property of the issuer and describe the condition of the properties. If the issuer does not have
complete ownership or control of the property (for example, if others also own the property or if there is a mortgage on the
property), describe the limitations on the ownership.
If the issuer leases any assets, properties or facilities, clearly describe them as above and the terms of their leases.
The Company maintains its headquarters in Tulsa, Oklahoma in space provided to the Company by it CEO and its not
subject to a lease.
0. 8) Officers, Directors, and Control Persons
The goal of this section is to provide an investor with a clear understanding of the identity of all the persons or entities that
are involved in managing, controlling or advising the operations, business development and disclosure of the issuer, as
well as the identity of any significant shareholders.
OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v1.1 April 25, 2013) Page 6 of 9
0. A. Names of Officers, Directors, and Control Persons. In responding to this item, please provide the names
of each of the issuer’s executive officers, directors, general partners and control persons (control persons are
beneficial owners of more than five percent (5%) of any class of the issuer’s equity securities), as of the date of
this information statement.
Joseph Francella (CEO)
0. B. Legal/Disciplinary History. Please identify whether any of the foregoing persons have, in the last five
years, been the subject of:
0. 1. A conviction in a criminal proceeding or named as a defendant in a pending criminal proceeding
(excluding traffic violations and other minor offenses);
None
0. 2. The entry of an order, judgment, or decree, not subsequently reversed, suspended or vacated, by a court
of competent jurisdiction that permanently or temporarily enjoined, barred, suspended or otherwise limited
such person’s involvement in any type of business, securities, commodities, or banking activities;
None
0. 3. A finding or judgment by a court of competent jurisdiction (in a civil action), the Securities and Exchange
Commission, the Commodity Futures Trading Commission, or a state securities regulator of a violation of
federal or state securities or commodities law, which finding or judgment has not been reversed, suspended,
or vacated; or
None
0. 4. The entry of an order by a self-regulatory organization that permanently or temporarily barred
suspended or otherwise limited such person’s involvement in any type of business or securities activities.
None
0. C. Beneficial Shareholders. Provide a list of the name, address and shareholdings or the
percentage of shares owned by all persons beneficially owning more than ten percent (10%) of any
class of the issuer’s equity securities. If any of the beneficial shareholders are corporate shareholders,
provide the name and address of the person(s) owning or controlling such corporate shareholders and
the resident agents of the corporate shareholders.
Joseph Francella c/o Limitless Venture Group, Inc., 121 E. 35 Street, Tulsa, OK 74105 1 holds 1 share constituting 100%
of the issued and outstanding shares of Series G Preferred Stock as of September 30, 2016.
OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v1.1 April 25, 2013) Page 7 of 9
0. 9) Third Party Providers
Please provide the name, address, telephone number, and email address of each of the following outside providers that
advise your company on matters relating to operations, business development and disclosure:
Legal Counsel
Name: Matthew Stout
Firm:
Address 1: 400 East Pratt Street, 8th Floor
Address 2: Baltimore, Maryland 21202
Phone:
Email:
Accountant or Auditor
Name:
Firm:
Address 1:
Address 2:
Phone:
Email:
Investor Relations Consultant
Name:
Firm:
Address 1:
Address 2:
Phone:
Email:
Other Advisor: Any other advisor(s) that assisted, advised, prepared or provided information with respect to this
disclosure statement.
Name:
Firm:
Address 1:
Address 2:
Phone:
Email:
OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v1.1 April 25, 2013) Page 8 of 9
0. 10) Issuer Certification
The issuer shall include certifications by the chief executive officer and chief financial officer of the issuer (or any other
persons with different titles, but having the same responsibilities).
The certifications shall follow the format below:
I, Joseph Francella certify that:
a. 1. I have reviewed this quarterly disclosure statement of Limitless Venture Group, Inc.;
a. 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this disclosure
statement; and
a. 3. Based on my knowledge, the financial statements, and other financial information included or
incorporated by reference in this disclosure statement, fairly present in all material respects the financial
condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this
disclosure statement.
February 22, 2017
/s/ JOSEPH FRANCELLA
/s/ JOSEPH FRANCELLA
(Digital Signatures should appear as “/s/ [OFFICER NAME]”)
Chief Executive Officer and Chief Financial Officer
OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v1.1 April 25, 2013) Page 9 of 9

[zakattack]

Hey at least he released them like he said he would. I'll give him credit for that